VHT is trading at $315.34, with a -5.22% change, amid healthcare weakness and broader risk-off pressures; reporting has not established a specific catalyst for the after-hours move.
- On October 23, the NYSE Healthcare Index fell 1.3%, while XLV declined 1.2%.
- Moderna and Merck were pressured by reports of a possible data leak; Bristol Myers Squibb fell after reporting a clinical-trial patient death.
- Middle East tensions and oil above $114 heightened inflation and supply-chain worries, weighing on risk appetite.